AASLD 2018: Rare Liver Toxicity With Checkpoint Inhibition Leads to Cessation of Immunotherapy
Hepatotoxicity is rare and does not lead to liver failure.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.